ClinicalTrials.govpublic full text
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
epilepsy, epilepsies, partial, rwj-333369, anticonvulsants, refractory partial epilepsy, seizure disorder, antiepileptic drugs, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1008827
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.